SOTIO Further Expands Next-Generation ADC Platform with License to Synaffix’s ADC Technology
SOTIO Provides Update on Interim Data from Clinical Trials of Nanrilkefusp Alfa
SOTIO Announces First Patients Dosed in Two Combination Arms of CLAUDIO-01 Study Evaluating SOT102 in First-Line Gastric and Pancreatic Cancer